IlluminOss Medical Raises $28M in Series C Financing

IlluminOss Medical, a manufacturer of photodynamic orthopedic implants, has secured a $28 million Series C round of venture capital financing.

Advertisement

The minimally invasive IlluminOss Photodynamic Bone Stabilization System is used to treat fractures through a small entry into the bone. A flexible balloon catheter is inserted into the bone, placed across the fracture site, and infused with a proprietary liquid monomer. The monomer then expands the balloon to assist in the alignment of the fractured bone, and surgeons use a visible light source to illuminate it and convert it into a hardened polymer implant.

More Articles on Orthopedic Devices:

Amedica Receives FDA Approval for Interbody Fusion Device

Smith & Nephew Devices Approved For Additional Indications

Alphatec Spine to Acquire Some Assets of Phygen

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.